Immobilized hematopoietic growth factors onto magnetic particles offer a scalable strategy for cell therapy manufacturing in suspension cultures

Hematopoietic therapies require high cell dosages and precise phenotype control for clinical success; scalable manufacturing processes therefore need to be economic and controllable, in particular with respect to culture medium and growth factor (GF) strategy. The aim of this work was to demonstrate...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew Worrallo, Rebecca L.L. Moore, Katie Glen, Rob Thomas
Format: Default Article
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/2134/23658
Tags: Add Tag
No Tags, Be the first to tag this record!